|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-11-5
|
|
pubmed:abstractText |
Ninety percent of all men with diabetes have Type II (non-insulin-dependent) diabetes mellitus, and erectile dysfunction (ED) is common in this patient group. This study evaluated the effects of sildenafil on men with erectile dysfunction and Type II diabetes and compared the results with glycated haemoglobin concentrations and chronic diabetic complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0012-186X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1296-301
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11692178-3',5'-Cyclic-GMP Phosphodiesterases,
pubmed-meshheading:11692178-Adult,
pubmed-meshheading:11692178-Aged,
pubmed-meshheading:11692178-Aged, 80 and over,
pubmed-meshheading:11692178-Diabetes Mellitus, Type 2,
pubmed-meshheading:11692178-Double-Blind Method,
pubmed-meshheading:11692178-Erectile Dysfunction,
pubmed-meshheading:11692178-Hemoglobin A, Glycosylated,
pubmed-meshheading:11692178-Humans,
pubmed-meshheading:11692178-Male,
pubmed-meshheading:11692178-Middle Aged,
pubmed-meshheading:11692178-Phosphodiesterase Inhibitors,
pubmed-meshheading:11692178-Piperazines,
pubmed-meshheading:11692178-Placebos,
pubmed-meshheading:11692178-Purines,
pubmed-meshheading:11692178-Sulfones,
pubmed-meshheading:11692178-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus.
|
|
pubmed:affiliation |
University of Manchester, Manchester, United Kingdom. ajmb@fs1.nwest.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
